Related references
Note: Only part of the references are listed.Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid
Sebastien Menzinger et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients
Murat Turk et al.
ALLERGOLOGY INTERNATIONAL (2018)
Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature
Igor Snast et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Our clinical experience with the use of omalizumab in the treatment of bullous pemphigoid
Pinar Incel Uysal et al.
TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY (2017)
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of Fc epsilon RI-positive cells in the skin
Martin Metz et al.
THERANOSTICS (2017)
Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid
Laura Sowerby et al.
JAMA DERMATOLOGY (2017)
Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity
Nina van Beek et al.
JAMA DERMATOLOGY (2017)
Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid
T. Hashimoto et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin
T. Nguyen et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2017)
Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature
Quentin Binet et al.
CASE REPORTS IN HEMATOLOGY (2017)
Successful Treatment of a Bullous Pemphigoid Patient with Rituximab Who Was Refractory to Corticosteroid and Omalizumab Treatments
Asli Bilgic Temel et al.
CASE REPORTS IN DERMATOLOGY (2017)
Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia
Nobuki Maki et al.
JOURNAL OF DERMATOLOGY (2016)
Bullous pemphigoid successfully treated with omalizumab
Muzeyyen Gonul et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2016)
Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up
A. Razzaque Ahmed et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature
G. Balakirski et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Rituximab in patients with recalcitrant autoimmune blistering diseases: experience in a cohort of 22 patients
D. Tomsitz et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
Y. T. Cho et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
C. Feliciani et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H-1 Antihistamines: A Randomized, Placebo-Controlled Study
Sarbjit S. Saini et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Remission Time after Rituximab Treatment for Autoimmune Bullous Disease: A Proposed Update Definition
Pilar Iranzo et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2015)
Remission of Bullous Pemphigoid after Rituximab Treatment in a Psoriasis Patient on Regular Low-dose Methotrexate
Ting-Shun Wang et al.
ACTA DERMATO-VENEREOLOGICA (2014)
Bullous Pemphigoid Associated with Acquired Hemophilia A: A Rare Association of Autoimmune Disease
Mohammed I. AlJasser et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2014)
Omalizumab therapy for bullous pemphigoid
Kenneth K. Yu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication
M. Kolesnik et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Refractory bullous pemphigoid with fatal outcome in a young patient
Maria Joao Cruz et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2013)
Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients
Russell P. Hall et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Refractory Childhood Pemphigoid Successfully Treated with Rituximab
Irene Fuertes et al.
PEDIATRIC DERMATOLOGY (2013)
Successful Treatment of Bullous Pemphigoid With Omalizumab
Vanessa A. London et al.
ARCHIVES OF DERMATOLOGY (2012)
Successful management of severe infant bullous pemphigoid with omalizumab
C. Dufour et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012
V. A. Venning et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Corticosteroid Use in Autoimmune Blistering Diseases
John W. Frew et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2012)
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Dedee F. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients
Michael Kasperkiewicz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients
S. Lourari et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Interventions for bullous pemphigoid
Gudula Kirtschig et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Risk Factors for Relapse in Patients With Bullous Pemphigoid in Clinical Remission
Philippe Bernard et al.
ARCHIVES OF DERMATOLOGY (2009)
Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab
Janet A. Fairley et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy
R. Saraceno et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2008)
Severe bullous pemphigoid in an infant - Successful treatment with rituximab
Johannes Schulze et al.
PEDIATRIC DERMATOLOGY (2008)
A new approach on bullous pemphigoid therapy
Z. Saouli et al.
ANNALS OF ONCOLOGY (2008)
Severe persistent pemphigoid gestationis:: long-term remission with rituximab
G. Cianchini et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Rituximab in autoimmune bullous diseases:: mixed responses and adverse effects
E. Schmidt et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Rituximab in refractory autoimmune bullous diseases
E. Schmidt et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: A case report and review of the literature
Jamie L. McGinness et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Share Paper
